It is a pharma private limited company based in Pune, Maharashtra, India, established in 1993.
1993 | Pune, Maharashtra, India | ActiveKanchan Drugs Pvt Ltd, a active private limited company, was established on 15 June 1993 in Pune, Maharashtra, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24299PN1993PTC072390. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Achyut Ashok Mhaskar (Director), Ajit Vinayak Ghate (Director), Suhas Vinayak Ghate (Director). It holds ₹14.67 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 326 Shaniwar Peth Sitaram Mansion, Pune, Maharashtra, 411030.
U24299PN1993PTC072390
072390
15 June 1993
₹1.50 M
₹1.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Kanchan Drugs Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Achyut Ashok Mhaskar | Director | 15 Jun 1993 | Current |
| Ajit Vinayak Ghate | Director | 15 Jun 1993 | Current |
| Suhas Vinayak Ghate | Director | 15 Jun 1993 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kanchan Drugs Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 3.99% increase. The company also saw a substantial improvement in profitability, with a 505.43% increase in profit. The company's net worth moved up by a moderate rise of 2.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kanchan Drugs had a public holding of 18.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹146,686,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2020 | Others | ₹6.00 M | Open |
| 23 Mar 2020 | Others | ₹2.00 M | Open |
| 09 Dec 2019 | Others | ₹5.00 M | Open |
| 26 Feb 2019 | Others | ₹4.00 M | Open |
| 04 Jan 2019 | Others | ₹0.35 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kanchan Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kanchan Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanchan Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kanchan Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Kanchan Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
A charge with Others amounted to Rs. 6.00 M with Charge ID 100340561 was registered on 20 May 2020. was recorded as a recent event.
A charge with Others amounted to Rs. 2.00 M with Charge ID 100336346 was registered on 23 Mar 2020. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 5.00 M with Charge ID 100311494 was registered on 09 Dec 2019. was completed.
The activity A charge with Others amounted to Rs. 4.00 M with Charge ID 100245641 was registered on 26 Feb 2019. was completed.
The CIN of Kanchan Drugs Pvt Ltd is U24299PN1993PTC072390.
Kanchan Drugs Pvt Ltd is headquartered at 326 Shaniwar Peth Sitaram Mansion, Pune, Maharashtra, 411030.
Kanchan Drugs Pvt Ltd was incorporated on 15 June 1993.
The current directors of Kanchan Drugs Pvt Ltd are
The primary industry of Kanchan Drugs Pvt Ltd is Hospital And Medical Care.
Kanchan Drugs Pvt Ltd is unlisted.
The authorized capital of Kanchan Drugs Pvt Ltd is ₹1.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Kanchan Drugs Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX